Lymphokines inhibit macrophage RNA synthesis

|March 1, 1984

Summary

Lymphokine preparations contain a novel RNA-labeling inhibitory factor (RIF) that suppresses macrophage RNA synthesis. This factor

Area of Science:

Background:

Lymphokines (LK) are crucial signaling molecules in immune responses.
Macrophage-activating factor (MAF) is a key lymphokine involved in macrophage activation.
The precise mechanisms by which LKs influence macrophage metabolism are not fully understood.

Purpose of the Study:

To investigate the effects of LK preparations on macrophage RNA synthesis.
To identify and characterize a novel factor within LK preparations that inhibits RNA labeling.
To explore the potential of this inhibitory factor as a tool for studying LK activity.

Main Methods:

Investigated [3H]uridine incorporation into macrophage RNA using LK preparations from activated murine spleen cells.
Assessed RNA-labeling inhibitory factor (RIF) activity in relation to macrophage-activating factor (MAF) activity.
Evaluated the role of lipopolysaccharide (LPS) as a costimulator and genetic control of the response.

Main Results:

LK preparations contained a potent RNA-labeling inhibitory factor (RIF) that significantly reduced [3H]uridine incorporation in macrophages.
RIF activity was distinct from altered cell permeability or precursor pool specific activity, indicating direct RNA metabolism interference.
RIF activity required LPS costimulation and showed genetic control, with C3H/HeJ macrophages being unresponsive.
RIF expression correlated strongly with MAF activity, suggesting a shared biological pathway.

Conclusions:

A novel RIF present in LK preparations inhibits macrophage RNA synthesis.
RIF activity is dependent on LPS and genetic factors, offering insights into macrophage activation pathways.
The RIF assay provides a valuable new method for quantifying macrophage-sensitive LK activity and aids in purification and screening.

Related Experiment Videos